Normal ex vivo mesenchymal stem cell function combined with abnormal immune profiles sets the stage for informative cell therapy trials in idiopathic pulmonary fibrosis patients

Elena Atanasova, Dragana Milosevic, Svetlana Bornschlegl, Karen P. Krucker, Eapen K. Jacob, Eva M. Carmona Porquera, Dagny K. Anderson, Ashley M. Egan, Andrew H. Limper, Allan B. Dietz

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Normal ex vivo mesenchymal stem cell function combined with abnormal immune profiles sets the stage for informative cell therapy trials in idiopathic pulmonary fibrosis patients'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds